Connect with us

News

Health Canada received more Johnson & Johnson data on same day as U.S. approval – CBC.ca

Published

 on


Health Canada on Saturday received additional data required to inform its decision on Johnson & Johnson’s COVID-19 vaccine — the same day the shot was approved in the United States.

“We were waiting on some manufacturing data, and that came in yesterday. So we’re starting to look at that,” Dr. Supriya Sharma, Health Canada’s chief medical adviser, said Sunday on Rosemary Barton Live.

“It’s really difficult to predict exactly when we might make a final decision because it really depends on that data. But we’re looking at … the next couple of weeks.”

The data received on Saturday is what health regulators need to ensure that “every dose of the vaccine that comes off the production lines meets quality standards,” Sharma wrote in an email to CBC News.

The approval timeline depends on that information, but it also depends on whether regulators need to discuss any questions that arise with the manufacturer. Work that happens in the final stages of review — including finalizing a risk-management plan for monitoring the vaccine after authorization — must also be completed.

The two-week approval target takes those steps into consideration but doesn’t account for unexpected issues that could crop up, Sharma said.

The government authorized the use of a third vaccine, the Oxford-AstraZeneca shot, on Friday.

WATCH | Johnson & Johnson vaccine approval could come in the next couple of weeks:

Health Canada’s chief medical adviser, Dr. Supriya Sharma, said the agency is waiting on manufacturer data to make a determination on Johnson & Johnson’s single-dose COVID-19 vaccine, but contingent on that data, approval could come in the next few weeks. 9:23

Single-dose shot makes for easier rollout

In a global trial, the Johnson & Johnson vaccine, which was cleared by the U.S. Food and Drug Administration (FDA) on Saturday, was found to be 66 per cent effective at staving off moderate to severe illness and was 85 per cent effective at preventing the most serious outcomes. 

Canada has ordered 10 million doses of the vaccine, with options for up to 28 million more. 

The best vaccine for an individual is [the] one that you can get.– Health Canada chief medical adviser Dr. Supriya Sharma

“In terms of the committee meeting that the FDA had, we had observers there as well, so all of that helps make for a more efficient review,” Sharma told CBC chief political correspondent Rosemary Barton.

While the vaccine was approved as a one-shot regimen, the company is also testing the efficacy of administering two doses of its product.

“If a vaccine is only only dose, then that makes it easier for administration. You don’t have to do the followup to record people and track them down to get the second dose,” Sharma told Barton. “So all of that helps, but what really helps the most is getting as many vaccines authorized and get that supply in as quickly as possible.”

Not a question of ‘good’ and ‘bad’ vaccines

Now that more vaccines are earning approvals, Sharma said a “narrative” has emerged where people assume one shot confers better protection than another.

Efficacy, she said, simply means determining whether “something does what it’s supposed to do.” As far as COVID-19 vaccines are concerned, that means comparing one group of people who receive the shot against another group of people who didn’t and contrasting the number of cases in both groups.

“When we look across all the vaccines, the major five that are under review and authorized, if you look at that subsection that matters most — severe disease, hospitalizations, dying of COVID-19 — all of these vaccines are equally protective,” Sharma explained.

The chief medical adviser cautioned against pitting one shot against another, something she said can only happen in a “head-to-head” trial, which would see two vaccines being tested together in the same trial.

“The best vaccine for an individual is [the] one that you can get. That’s pretty simple,” she said.

“For people who are sitting back and waiting for another vaccine, I would say the longer, and the more people, who do that, the more we’re all going to be sitting at home if we’re lucky to have a home.”

You can watch full episodes of Rosemary Barton Live on CBC Gem, the CBC’s streaming service. 

Let’s block ads! (Why?)



Source link

Continue Reading

News

Citigroup lawyer says another bank made bigger payment error than Revlon

Published

 on

NEW YORK (Reuters) – A lawyer for Citigroup Inc told a U.S. judge on Friday he was aware of another large bank that recently made a bigger payment error than Citigroup made last August when it sent $894 million of its own money to Revlon Inc lenders.

Neal Katyal, the lawyer, made the disclosure at a hearing in Manhattan federal court, where Citigroup urged U.S. District Judge Jesse Furman to extend a freeze on $504 million that it has been unable to recoup from the Revlon lenders.

Katyal did not identify the bank, the size of the payment error, or whether the error was fixed.

Citigroup is appealing Furman’s Feb. 16 decision that 10 asset managers, whose clients include Revlon lenders, could keep its mistaken payments.

Furman accepted the asset managers’ argument that Citigroup, as Revlon’s loan agent, paid what they were owed, and they had no reason to think a sophisticated bank would blunder so badly.

Citigroup has said the lenders received a “windfall,” and Furman’s decision could steer banks away from doing wire transfers in a “finders, keepers” marketplace.

Katyal is a partner at Hogan Lovells and former Acting U.S. Solicitor General. Citigroup hired him for its appeal.

 

(Reporting by Jonathan Stempel in New York; editing by Diane Craft)

Continue Reading

News

Canada aims to raise safety along notorious “Highway of Tears” with cell phone service

Published

 on

By Moira Warburton

VANCOUVER (Reuters) – Canadian authorities will help fund mobile phone service to increase safety along a remote stretch of highway in British Columbia known as the “Highway of Tears” for the number of women who have gone missing on the route, most of them indigenous.

Indigenous groups recommended the move in 2006 in a report on disappearances and murders of women along the highway between the cities of Prince Rupert and Prince George, roughly 800 km (500 miles) north of Vancouver.

The recommendation was endorsed by a provincial government-mandated commission several years later.

The Royal Canadian Mounted Police are investigating 13 cases of murdered women and five who disappeared on or near the Highway of Tears, although no new cases have been added since 2007. Advocates believe the number of homicides and missing is significantly higher.

Lisa Beare, British Columbia’s minister of citizens’ services, called the project “a critical milestone in helping prevent future tragedies along this route.”

Cell phone plans in Canada are among the most expensive in the world, according to government data, and the cost and lack of coverage in rural areas was a top issue in the last election.

The provincial and federal governments will contribute C$4.5 million towards the C$11.6 million ($9.24 million) cost for Rogers Communications to install 12 cell phone towers, the British Columbia government said on Wednesday.

Lorraine Whitman, president of the Native Women’s Association of Canada, applauded the plan but said it was only one step in making the area safer for indigenous women.

“This truly is a blessing for the women,” she said. “But not all women have a phone. These towers are being put up, but it makes no use to the person that has no cell phone.”

($1 = 1.2558 Canadian dollars)

 

(Reporting by Moira Warburton in Vancouver; Editing by Sonya Hepinstall)

Continue Reading

News

Canadian fertilizer producer Nutrien to cut greenhouse gas emissions 30% by 2030

Published

 on

By Rod Nickel and Rithika Krishna

(Reuters) –Canada‘s Nutrien Ltd, the world’s largest fertilizer producer by capacity, said on Thursday it aimed to cut greenhouse gas emissions by at least 30% by 2030, in a plan costing the company up to $700 million.

Agricultural companies, including Mosaic and Corteva, have set carbon emissions targets as climate-conscious investors push firms to become more environmentally friendly.

Nutrien plans to spend $500 million to $700 million to meet the carbon emissions target, which includes cutting emissions from nitrogen production by 1 million tonnes of carbon dioxide equivalent annually by the end of 2023.

“We’re in a really unique spot to address two big societal challenges – food security, and in a way that reduces our environmental footprint,” said Mark Thompson, Nutrien’s chief corporate development and strategy officer, in an interview.

Synthetic fertilizers account for 12% of global emissions from agriculture, according to a 2016 United Nations Food and Agriculture Organization report.

Nutrien’s target includes Scope 1 and 2 emissions, which reflect direct operations and electricity use. Nutrien is addressing Scope 3 emissions – those related to on-farm activity – with a program that encourages growers to adopt sustainable practices that generate monetary credits.

The Saskatoon, Saskatchewan-based company plans to deploy wind and solar energy at four potash plants by the end of 2025, replacing electricity generated by coal and natural gas.

It also plans to expand its sequestration of carbon emissions from nitrogen fertilizer production and to invest in technology to capture nitrous oxide gas from its facilities.

Nutrien estimates that its carbon credit program could directly amount to $10 to $20 per acre for farmers, and it expects to benefit financially itself as well.

“If we can provide agronomic value and the value of the carbon credit over time, we’ll have customer loyalty – we anticipate that we’ll be a preferred supplier,” Thompson said.

(Reporting by Rithika Krishna in Bengaluru and Rod Nickel in Winnipeg; Editing by Sriraj Kalluvila and Steve Orlofsky)

Continue Reading

Trending